214 related articles for article (PubMed ID: 2543994)
1. Antiviral effects of phosphonoformate (PFA, foscarnet sodium).
Oberg B
Pharmacol Ther; 1989; 40(2):213-85. PubMed ID: 2543994
[TBL] [Abstract][Full Text] [Related]
2. Antiviral effects of phosphonoformate (PFA, foscarnet sodium).
Oberg B
Pharmacol Ther; 1982; 19(3):387-415. PubMed ID: 6201932
[No Abstract] [Full Text] [Related]
3. Inhibition of herpesvirus multiplication in guinea pig skin by antiviral compounds.
Alenius S
Arch Virol; 1980; 65(2):149-56. PubMed ID: 6252867
[TBL] [Abstract][Full Text] [Related]
4. Herpes simplex virus hepatitis in mice: effects of treatment with trisodium phosphonoformate.
Ulbricht A; Färber I; Wutzler P
Acta Virol; 1985 Dec; 29(6):493-8. PubMed ID: 2869661
[TBL] [Abstract][Full Text] [Related]
5. Effect of trisodium phosphonoformate and idoxuridine on experimental herpes simplex keratitis in immunized and non-immunized rabbits.
Alenius S; Laurent U; Oberg B
Acta Ophthalmol (Copenh); 1980 Apr; 58(2):167-73. PubMed ID: 6249066
[TBL] [Abstract][Full Text] [Related]
6. [Antiviral activity of phosphonoacetic acid, phosphonopropionic acid, and trisodium phosphonoformate hexahydrate against herpesvirus hominis type 1 and type 2 in vitro].
Thiel KD; Wutzler P; Sprössig M; Bertram D
Pharmazie; 1982 Aug; 37(8):608. PubMed ID: 6292963
[No Abstract] [Full Text] [Related]
7. In vitro inhibition of human herpesvirus-6 by phosphonoformate.
Streicher HZ; Hung CL; Ablashi DV; Hellman K; Saxinger C; Fullen J; Salahuddin SZ
J Virol Methods; 1988 Sep; 21(1-4):301-4. PubMed ID: 2972736
[TBL] [Abstract][Full Text] [Related]
8. Synergism among BIOLF-62, phosphonoformate, and other antiherpetic compounds.
Smith KO; Galloway KS; Ogilvie KK; Cheriyan UO
Antimicrob Agents Chemother; 1982 Dec; 22(6):1026-30. PubMed ID: 6297382
[TBL] [Abstract][Full Text] [Related]
9. [Effectiveness of phosphonoformic acid in herpes infections].
Smejkal F; Otová B; Zikán V; Roubínek F
Cesk Farm; 1992 Feb; 41(1):1-4. PubMed ID: 1316808
[TBL] [Abstract][Full Text] [Related]
10. Combinations of 3'-azido-3'-deoxythymidine (zidovudine) and phosphonoformate (foscarnet) against human immunodeficiency virus type 1 and cytomegalovirus replication in vitro.
Eriksson BF; Schinazi RF
Antimicrob Agents Chemother; 1989 May; 33(5):663-9. PubMed ID: 2546487
[TBL] [Abstract][Full Text] [Related]
11. Foscarnet.
Lancet; 1985 Sep; 2(8456):648-9. PubMed ID: 2863637
[No Abstract] [Full Text] [Related]
12. No in vivo effect of trisodium phosphonoformate on woodchuck hepatitis virus production.
Nordenfelt E; Widell A; Hansson BG; Löfgren B; Möller-Nielsen C; Oberg B
Acta Pathol Microbiol Immunol Scand B; 1982 Dec; 90(6):449-51. PubMed ID: 6220563
[TBL] [Abstract][Full Text] [Related]
13. Trisodium phosphonoformate inhibits woodchuck hepatitis virus associated DNA polymerase.
Nordenfelt E; Werner B
Acta Pathol Microbiol Scand B; 1980 Jun; 88(3):183-4. PubMed ID: 6449828
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of HTLV-III/LAV replication by foscarnet.
Sarin PS; Taguchi Y; Sun D; Thornton A; Gallo RC; Oberg B
Biochem Pharmacol; 1985 Nov; 34(22):4075-9. PubMed ID: 2415134
[No Abstract] [Full Text] [Related]
15. Phosphonoformate inhibits reverse transcriptase.
Sundquist B; Oberg B
J Gen Virol; 1979 Nov; 45(2):273-81. PubMed ID: 94344
[TBL] [Abstract][Full Text] [Related]
16. Mode of action of phosphonoformate as an anti-herpes simplex virus agent.
Cheng YC; Grill S; Derse D; Chen JY; Caradonna SJ; Connor K
Biochim Biophys Acta; 1981 Jan; 652(1):90-8. PubMed ID: 6260189
[TBL] [Abstract][Full Text] [Related]
17. Clinical experiences with phosphonoformate (foscarnet) treatment of viral diseases following renal transplantation.
Ahlmén J; Wijnween AC; Brynger H; Lycke E
Scand J Urol Nephrol Suppl; 1985; 92():41-4. PubMed ID: 3008316
[TBL] [Abstract][Full Text] [Related]
18. In vitro recovery of resistant retrovirus isolates after exposure to phosphonoformate.
Muratore O; Varnier OE; Raffanti SP; Schito GC
Eur J Clin Microbiol; 1984 Oct; 3(5):447-9. PubMed ID: 6238823
[No Abstract] [Full Text] [Related]
19. Comparison of foscarnet cream, acyclovir cream, and acyclovir ointment in the topical treatment of experimental cutaneous herpes simplex virus type 1 infection.
Spruance SL; Freeman DJ; Sheth NV
Antimicrob Agents Chemother; 1986 Jul; 30(1):196-8. PubMed ID: 2944480
[TBL] [Abstract][Full Text] [Related]
20. Trisodium phosphonoformate, a new antiviral compound.
Helgstrand E; Eriksson B; Johansson NG; Lannerö B; Larsson A; Misiorny A; Norén JO; Sjöberg B; Stenberg K; Stening G; Stridh S; Oberg B
Science; 1978 Sep; 201(4358):819-21. PubMed ID: 210500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
